In Vivo Cell Biology Approach to Defining the Natural History of HHT-Associated AVMs

In 2011, Dr. Beth Roman, Assistant Professor in the Department of Biological Sciences at the University of Pittsburgh, received a $45,000 grant from Cure HHT for her research entitled, “In Vivo Cell Biology Approach to Defining the Natural History of HHT-Associated AVMs.” The goal of Dr. Roman’s research is to understand the molecular and cellular errors that lead to HHT-associated arteriovenous malformations (AVMs). Read her final report to learn all that was discovered.